Combating the Chronic Disease Epidemic Through Innovative Laboratory Testing
Beginning in 2025 federal health agencies are prioritizing initiatives that help to prevent chronic diseases, a departure from the historic focus on treating late stage disease.
Our Coalition is engaging with leaders of these agencies and members of Congress to drive home the critical role of innovative diagnostics to help prevent, detect early, and manage chronic diseases such as diabetes, heart disease and strokes, cancers, dementia and Alzheimer’s, and mental illness.
We are advocating for federal policies that help clinical labs contribute to the goals of Make America Healthy Again and improve healthy aging while reducing costs to our healthcare system.
Resisting FDA Overregulation
The Coalition for Innovative Lab Testing exists to keep new, accurate, and reliable diagnostic tests available by pushing back against what it sees as harmful government overreach. They argue that existing federal and state CLIA rules already ensure test quality and that adding FDA pre-approval requirements would slow innovation and endanger patient access to critical diagnostics.
Formed in January 2021, the coalition brings together clinical laboratories, entrepreneurs, scientists, healthcare providers, and citizens who oppose legislation like the VALID Act. Their mission is to preserve a regulatory environment where labs can develop and deploy novel tests quickly—especially in emergencies—without facing what they call “deadly overregulation”
